UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
---|---|---|---|---|
Q2FYI5 (GPSB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Cell cycle protein GpsB; Guiding PBP1-shuttling protein; | |
Q2FXU4 (SYH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Histidine--tRNA ligase; Histidyl-tRNA synthetase; | |
Q2FXS8 (RL21_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein bL21; 50S ribosomal protein L21; | |
Q2FXT0 (RL27_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein bL27; 50S ribosomal protein L27; | |
Q2FZ38 (RNH2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribonuclease HII; | |
Q2FUS6 (PCP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Pyrrolidone-carboxylate peptidase; 5-oxoprolyl-peptidase; Pyroglutamyl-peptidase I; | |
Q2G1X0 (HLA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Alpha-hemolysin; Alpha-toxin; | |
Q2FV22 (PANC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Pantothenate synthetase; Pantoate--beta-alanine ligase; Pantoate-activating enzyme; | |
Q2FZP6 (MURE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--L-lysine ligase; L-lysine-adding enzyme; UDP-MurNAc-L-Ala-D-Glu:L-Lys ligase; UDP-MurNAc-tripeptide synthetase; UDP-N-acetylmuramyl-tripeptide synthetase; | |
Q2FXY3 (NADD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable nicotinate-nucleotide adenylyltransferase; Deamido-NAD(+) diphosphorylase; Deamido-NAD(+) pyrophosphorylase; Nicotinate mononucleotide adenylyltransferase; | |
Q2G157 (NANE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative N-acetylmannosamine-6-phosphate 2-epimerase; ManNAc-6-P epimerase; | |
Q2G2M8 (NTDP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Nucleoside triphosphate/diphosphate phosphatase; Nucleoside diphosphatase; | |
Q2FXS9 (PRP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosomal processing cysteine protease Prp; Phage-related ribosomal protease; | |
Q2FW19 (RS14Z_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Small ribosomal subunit protein uS14B; 30S ribosomal protein S14 type Z; | |
Q2FWY8 (GATC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C; | |
Q2G1U0 (KGUA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Guanylate kinase; GMP kinase; | |
Q2FXX8 (MTNN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase; 5'-deoxyadenosine nucleosidase; 5'-methylthioadenosine nucleosidase; S-adenosylhomocysteine nucleosidase; | |
Q2FZD2 (THIO_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Thioredoxin; | |
Q2FZ89 (FTSZ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Cell division protein FtsZ; | |
Q2FUS8 (DRP35_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Lactonase drp35; | |
Q2G2S0 (PUR8_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Adenylosuccinate lyase; Adenylosuccinase; | |
Q2FZF1 (RL32_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Large ribosomal subunit protein bL32; 50S ribosomal protein L32; | |
Q2G222 (Y2979_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | N-acetylmuramoyl-L-alanine amidase domain-containing protein SAOUHSC_02979; | |
Q2G2U6 (WALR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcriptional regulatory protein WalR; | |
Q2G261 (SODM2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Superoxide dismutase [Mn/Fe] 2; | |
Q2FYN7 (DAPH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase; Tetrahydrodipicolinate N-acetyltransferase; | |
Q2FXC4 (SPLC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Serine protease SplC; | |
Q2FWC1 (PDP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Pyrimidine-nucleoside phosphorylase; | |
Q2G1B9 (TARJ1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribulose-5-phosphate reductase 1; Ribitol-5-phosphate dehydrogenase 1; | |
Q2FWM8 (HLD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Delta-hemolysin; Delta-toxin; | |
Q2FZE6 (ISDE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | High-affinity heme uptake system protein IsdE; Iron-regulated surface determinant protein E; Staphylococcal iron-regulated protein F; | |
Q2G0P6 (MCSB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Protein-arginine kinase; | |
Q2G236 (NADE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | NH(3)-dependent NAD(+) synthetase; | |
Q2FXM8 (PFKA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP-dependent 6-phosphofructokinase; Phosphohexokinase; | |
Q2FYF1 (EBPS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Elastin-binding protein EbpS; | |
Q2FZ44 (RIMM_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosome maturation factor RimM; | |
Q2G241 (SYE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glutamate--tRNA ligase; Glutamyl-tRNA synthetase; | |
Q2FYD8 (PH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable autolysin PH; | |
Q2G1G5 (PTXBC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | PTS system MurNAc-GlcNAc-specific EIIBC component; MurNAc-GlcNAc-specific phosphotransferase enzyme IIB component; 2.7.1.-; PTS system MurNAc-GlcNAc-specific EIIB component; MurNAc-GlcNAc permease IIC component; PTS system MurNAc-GlcNAc-specific EIIC component; | |
P0A084 (MSRA1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptide methionine sulfoxide reductase MsrA 1; Peptide-methionine (S)-S-oxide reductase 1; | |
Q2FZP9 (Y951_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative phosphoesterase SAOUHSC_00951; | |
Q2FW66 (ASP23_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Alkaline shock protein 23; | |
Q2G0K8 (NAGB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glucosamine-6-phosphate deaminase; GlcN6P deaminase; Glucosamine-6-phosphate isomerase; | |
Q2G1E1 (HPTR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Transcriptional regulatory protein HptR; | |
Q2FV57 (CRTP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 4,4'-diaponeurosporene oxygenase; 4,4'-diaponeurosporene oxidase; Carotenoid oxidase; | |
Q2FV56 (CRTO_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycosyl-4,4'-diaponeurosporenoate acyltransferase; | |
Q2G2V3 (MENE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-succinylbenzoate--CoA ligase; o-succinylbenzoyl-CoA synthetase; | |
Q2FZI6 (PUR9_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Bifunctional purine biosynthesis protein PurH; Phosphoribosylaminoimidazolecarboxamide formyltransferase; 2.1.2.3; AICAR transformylase; IMP cyclohydrolase; 3.5.4.10; ATIC; IMP synthase; Inosinicase; | |
Q2FYS4 (PARC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | DNA topoisomerase 4 subunit A; Topoisomerase IV subunit A; | |
Q2FW23 (RS5_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Small ribosomal subunit protein uS5; 30S ribosomal protein S5; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2024_02 that was used for the most up to date SWISS-MODEL Repository.
Proteins in proteome | Sequences modelled | Models |
2,889 | 2,347 | 3,751 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 21-mer | 24-mer | 25-mer | 40-mer | 60-mer |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,387 | 949 | 75 | 190 | 6 | 80 | 6 | 18 | 2 | 7 | 13 | 3 | 4 | 1 | 7 | 1 | 1 | 1 |